Beta-2 Microglobulin Predicts Lupus Nephritis, SLE Disease Activity
Serum beta-2 microglobulin can be used to monitor kidney damage in systemic lupus erythematosus for earlier diagnosis of lupus nephritis.
All articles by Natasha Persaud
Home Dialysis Increased After Financial Incentives Implemented
Upward trend follows debut of the federal End-Stage Renal Disease Treatment Choices payment model in January 2021.
Safety of SGLT2 Inhibitors vs GLP-1RAs in CKD, Type 2 Diabetes
The slow clinical adoption of sodium-glucose cotransporter-2 inhibitors may partly be due to concerns about potential adverse effects, investigators suggested.
Kidney Graft Loss Risk Higher in BK Polyomavirus-Associated Nephropathy
While uncommon, BK polyomavirus-associated nephropathy is associated with a “substantial” risk of graft loss in kidney transplant recipients.
Major Hemorrhage Risk Increased Among Older Adults With CKD
ASPREE trial data offered a “unique opportunity” to assess bleeding risk in older populations with and without CKD.
Dapagliflozin Lowers Cardiovascular Risks, Uric Acid Regardless of Gout Status
Latest findings are from a post hoc meta-analysis of pooled data from the DAPA-HF and DELIVER trials.
Suboptimal RAASi Therapy After Hyperkalemia Ups Cardiorenal Risks
Guidelines support the use of RAASi at the maximum tolerated dose in patients with CKD and heart failure.
Glycated Albumin to HbA1c Ratio Predicts Death in Dialysis Population With Diabetes
The ratio is a clinically meaningful indicator that is easily obtained from blood test results, according to investigators.
AKI Risk Lower With SGLT2 vs DPP4 Inhibitor in Type 2 Diabetes
Despite a warning from the FDA Adverse Event Reporting System, studies have found that SGLT2 inhibitor use is not associated with an increased risk of AKI.
High Plant Intake May Protect Against Prostate Cancer Progression, Recurrence
Dietary counseling may improve clinical outcomes for men with prostate cancer.
- Loading...
Loading...
Next post in Genitourinary Cancers Symposium
Loading... 
Loading...